1. Endothelins: circulating plasma levels and presence in other biological fluids;BATTISTINI;Lab. Invest.,1993
2. Influence of an ETA-receptor antagonist on regional haemodynamic responses to endothelin-1 (ET-1) and [Ala11, 15]Ac-ET-1(6-21) in conscious rats;BENNETT;Br. J. Pharmacol.,1993
3. Discrimination between ETA-and ETB-receptor-mediated effects of endothelin-1 and [Ala1, 3,11, 15] endothelin-1 by BQ-123 in the anaesthetized rat;BIGAUD;Br. J. Pharmacol.,1992
4. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist;CLOZEL;Nature,1993
5. Pharmacological characterization of bosentan, a new potent orally active non-peptide endothelin receptor antagonist;CLOZEL;J. Pharmacol. Exp. Ther.,1994